Prestige Consumer Healthcare to Release Fiscal 2025 First Quarter Earnings Results
Prestige Consumer Healthcare to Release Fiscal 2025 First Quarter Earnings Results
TARRYTOWN, N.Y., July 02, 2024 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2025 first quarter earnings release on Thursday, August 8, 2024 before the opening of the market. The Company will host a conference call to discuss the results that same morning at 8:30 a.m. ET.
普雷斯蒂奇消费保健公司（NYSE：PBH）今日宣布，将于2024年8月8日（星期四）早盘开市前发布2025财年第一季度财报，公司将于当天上午8:30 ET召开电话会议讨论财报结果。
To participate in the live Internet webcast of the conference call, it can be accessed from the Investor Relations page of . To participate in the conference call via phone, participants may register for the call here to receive dial-in details and a unique pin. While not required, it is recommended to join 10 minutes prior to the event start.
为参加电话会议的网络直播，请登录投资者关系页面。参加电话会议的人可以在这里注册，以获取撥號詳情和獨特的PIN碼。虽然不是必需的，但建议提前10分钟加入，以免错过任何重要信息。
A conference call replay will be available for approximately one week following completion of the live call and can be accessed on the Company's Investor Relations page.
电话会议重播将于直播结束后大约一周内提供，并可在公司的投资者关系页面上访问。
About Prestige Consumer Healthcare Inc.
关于普雷斯蒂奇公司
Prestige Consumer Healthcare markets, sells, manufactures and distributes consumer healthcare products to retail outlets throughout the U.S. and Canada, Australia, and in certain other international markets. The Company's diverse portfolio of brands include Monistat and Summer's Eve women's health products, BC and Goody's pain relievers, Clear Eyes and TheraTears eye care products, DenTek specialty oral care products, Dramamine motion sickness treatments, Fleet enemas and glycerin suppositories, Chloraseptic and Luden's sore throat treatments and drops, Compound W wart treatments, Little Remedies pediatric over-the-counter products, Boudreaux's Butt Paste diaper rash ointments, Nix lice treatment, Debrox earwax remover, Gaviscon antacid in Canada, and Hydralyte rehydration products and the Fess line of nasal and sinus care products in Australia. Visit the Company's website at .
普雷斯蒂奇消费保健公司将消费保健产品销售、制造和分销到美国和加拿大的零售店，澳大利亚以及某些其他国际市场。公司的品牌组合包括Monistat和Summer's Eve女性保健产品，BC和Goody's止痛药，Clear Eyes和TheraTears眼部护理产品，DenTek特殊口腔护理产品，Dramamine晕动病治疗，Fleet灌肠和甘油栓，Chloraseptic和Luden的喉咙治疗和口腔消毒药物，Compound W疣的治疗，Little Remedies小儿用成药，Boudreaux's Butt Paste尿布疹药，Nix杀虱剂，Debrox耳垢清除剂，Gaviscon加拿大抗酸剂，以及澳大利亚的Hydralyte补水产品和Fess系列的鼻腔和鼻窦护理产品。请访问公司的网站。
Investor Relations Contact
Phil Terpolilli, CFA, 914-524-6819
irinquiries@prestigebrands.com
投资者关系联系人
Phil Terpolilli，CFA，914-524-6819
irinquiries@prestigebrands.com
Source: Prestige Consumer Healthcare Inc.
来源：普雷斯蒂奇公司。